๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

UCB Pharma S.A. โ€” Licensed Medicines

41 medicines held by UCB Pharma S.A. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 41 products held by UCB Pharma S.A.
MedicineActive substanceLicence holderStatus
10 mg/ml Solution for infusion
EU/1/19/1383/001-002
Lacosamide UCB Pharma S.A. โ€”
Bimzelx 160 mg solution for injection in pre-filled pen
EU/1/21/1575/005-008
Bimekizumab UCB Pharma S.A. โ€”
Bimzelx 160 mg solution for injection in pre-filled syringe
EU/1/21/1575/001-004
Bimekizumab UCB Pharma S.A. โ€”
Briviact 10 mg film-coated tablets
EU/1/15/1073/001-004
Brivaracetam UCB Pharma S.A. โ€”
Briviact 10 mg/ml oral solution
EU/1/15/1073/021
Brivaracetam UCB Pharma S.A. โ€”
Briviact 10 mg/ml solution for injection/infusion
EU/1/15/1073/022
Brivaracetam UCB Pharma S.A. โ€”
Briviact 100 mg film-coated tablets
EU/1/15/1073/017-020
Brivaracetam UCB Pharma S.A. โ€”
Briviact 25 mg film-coated tablets
EU/1/15/1073/005-008
Brivaracetam UCB Pharma S.A. โ€”
Briviact 50 mg film-coated tablets
EU/1/15/1073/009-012
Brivaracetam UCB Pharma S.A. โ€”
Briviact 75 mg film-coated tablets
EU/1/15/1073/013-016
Brivaracetam UCB Pharma S.A. โ€”
Cimzia 200 mg solution for injection in pre-filled syringe
EU/1/09/544/1-2
Certolizumab pegol UCB Pharma S.A. โ€”
EVENITY 105 mg solution for injection in pre-filled pen
EU/1/19/1411/001-002
ROMOSOZUMAB UCB Pharma S.A. โ€”
EVENITY 105 mg solution for injection in pre-filled syringe
EU/1/19/1411/003-004
ROMOSOZUMAB UCB Pharma S.A. โ€”
Fintepla 2.2 mg/ml oral solution
EU/1/20/1491/001-004
Fenfluramine hydrochloride UCB Pharma S.A. โ€”
Keppra 100 mg/ml concentrate for solution for infusion
EU/1/00/146/033
Levetiracetam UCB Pharma S.A. โ€”
Keppra 100 mg/ml oral solution
EU/1/00/146/027
Levetiracetam UCB Pharma S.A. โ€”
Keppra 1000 mg film-coated tablets
EU/1/00/146/020-026
Levetiracetam UCB Pharma S.A. โ€”
Keppra 250 mg film-coated tablets
EU/1/00/146/001-005
Levetiracetam UCB Pharma S.A. โ€”
Keppra 500 mg film-coated tablets
EU/1/00/146/006-013
Levetiracetam UCB Pharma S.A. โ€”
Keppra 750 mg film-coated tablets
EU/1/00/146/014-019
Levetiracetam UCB Pharma S.A. โ€”
Lacosamide UCB 10 mg/ml Syrup
EU/1/19/1383/003
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 100 mg Film-coated tablet
EU/1/19/1383/010-015
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 150 mg Film-coated tablet
EU/1/19/1383/016-021
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 200 mg Film-coated tablet
EU/1/19/1383/022-027
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 50 mg Film-coated tablet
EU/1/19/1383/004-009
Lacosamide UCB Pharma S.A. โ€”
Neupro
EU/1/05/331/1-3,14-20
Rotigotine UCB Pharma S.A. โ€”
Neupro
EU/1/05/331/38-46
Rotigotine UCB Pharma S.A. โ€”
Neupro
EU/1/05/331/47-55
Rotigotine UCB Pharma S.A. โ€”
Rystiggo 140 mg/ml solution for injection
EU/1/23/1780/001
Rozanolixizumab UCB Pharma S.A. โ€”
Vimpat 10 mg/ml solution for infusion
EU/1/08/470/16
Lacosamide UCB Pharma S.A. โ€”
Vimpat 10 mg/ml syrup
EU/1/08/470/018-019
Lacosamide UCB Pharma S.A. โ€”
Vimpat 100 mg film-coated tablets
EU/1/08/470/4-6
Lacosamide UCB Pharma S.A. โ€”
Vimpat 15 mg/ml syrup
EU/1/08/470/14-15
Lacosamide UCB Pharma S.A. โ€”
Vimpat 150 mg film-coated tablets
EU/1/08/470/7-9
Lacosamide UCB Pharma S.A. โ€”
Vimpat 200 mg film-coated tablets
EU/1/08/470/10-12
Lacosamide UCB Pharma S.A. โ€”
Vimpat 50 mg film-coated tablets
EU/1/08/470/1-3
Lacosamide UCB Pharma S.A. โ€”
Vimpat 50mg/ 100mg/ 150mg film-coated tablets
EU/1/08/470/13
Lacosamide UCB Pharma S.A. โ€”
Xyrem 500 mg/mL oral solution
EU/1/05/312/001
Sodium Oxybate UCB Pharma S.A. โ€”
Zilbrysq 16.6 mg solution for injection in pre-filled syringe
EU/1/23/1764/001-002
Zilucoplan UCB Pharma S.A. โ€”
Zilbrysq 23 mg solution for injection in pre-filled syringe
EU/1/23/1764/003-004
Zilucoplan UCB Pharma S.A. โ€”
Zilbrysq 32.4 mg solution for injection in pre-filled syringe
EU/1/23/1764/005-006
Zilucoplan UCB Pharma S.A. โ€”

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.